LABORATORY REPORT
Patient: John Smith, MRN: 12345
Date: December 15, 2024
Ordering Physician: Dr. Sarah Johnson

COMPREHENSIVE METABOLIC PANEL:

Glucose: 142 mg/dL (High — Reference: 70–100)

BUN: 18 mg/dL (Normal)

Creatinine: 0.9 mg/dL (Normal)

Sodium: 140 mEq/L (Normal)

Potassium: 4.2 mEq/L (Normal)

Chloride: 102 mEq/L (Normal)

CO₂: 24 mEq/L (Normal)

Calcium: 9.8 mg/dL (Normal)

Total Protein: 7.2 g/dL (Normal)

Albumin: 4.1 g/dL (Normal)

AST: 28 U/L (Normal)

ALT: 32 U/L (Normal)

Alkaline Phosphatase: 85 U/L (Normal)

LIPID PANEL:

Total Cholesterol: 195 mg/dL (Normal)

HDL: 45 mg/dL (Normal)

LDL: 128 mg/dL (Borderline High)

Triglycerides: 110 mg/dL (Normal)

HEMOGLOBIN A1C:

HbA1c: 8.1% (High — Target <7%)

COMPLETE BLOOD COUNT:

WBC: 7.2 K/µL (Normal)

RBC: 4.5 M/µL (Normal)

Hemoglobin: 13.8 g/dL (Normal)

Hematocrit: 41% (Normal)

Platelets: 285 K/µL (Normal)

URINALYSIS:

Specific Gravity: 1.015 (Normal)

pH: 6.0 (Normal)

Protein: Negative

Glucose: 2+ (Positive)

Ketones: Negative

Blood: Negative

INTERPRETATION:

Elevated glucose and HbA1c consistent with diabetes

Glucose in urine indicates poor glycemic control

Lipid panel shows borderline high LDL

All other values within normal limits

RECOMMENDATIONS:

Tighten glycemic control

Consider medication adjustment

Repeat HbA1c in 3 months

Consider statin therapy (or intensification) for LDL management